Adial Pharmaceuticals CEO Cary Claiborne explains to our hosts the company’s collaboration with Molteni and how their research aims to advance treatments for addiction and substance use disorders.
February 7, 2023
Adial Pharmaceuticals CEO Cary Claiborne explains to our hosts the company’s collaboration with Molteni and how their research aims to advance treatments for addiction and substance use disorders.
Other Interviews
